TP53 and neoplasm: Clinical studies have shown that macrophages can release cytotoxic molecules, such as reactive nitrogen intermediates, reactive oxygen intermediates, and a migration inhibitory factor during chronic inflammation, leading to DNA mutation and defective p53 activity in the surrounding epithelial cells, thereby predisposing these cells to premalignant transformation and tumor initiation.